Kintegral Advisory’s Covetrus, Inc. Common Stock CVET Stock Holding History
Bought
Maintained
Sold
Other funds holding CVET
Kintegral Advisory's CVET Position: Q4 2022 in Review
Kintegral Advisory sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 15,806 shares — an estimated $330K sold.
Kintegral Advisory first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $453K in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.
- Kintegral Advisory reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Kintegral Advisory sold 15,806 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $330K.
- Kintegral Advisory first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
- Kintegral Advisory's Covetrus, Inc. Common Stock position peaked at $453K in Q1 2021.
- 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.
Based on Kintegral Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.